Appeals Court Preserves False Claims Act Whistleblower Suits in Unanimous Ruling

A unanimous panel reversed the constitutional ruling

ATLANTA — A federal appeals court ruled unanimously September 1 that private whistleblowers may continue filing False Claims Act lawsuits on behalf of the United States, reversing a trial judge who had found the arrangement unconstitutional.

The Eleventh Circuit held that a person who brings a so-called qui tam action is not an officer of the United States who must be formally appointed under Article II. The panel said a relator lacks a continuing position established by federal law and instead pursues a particular case under powers Congress defined.

The decision restores the lawsuit brought by Clarissa Zafirov against Florida health-care organizations. It does not decide whether the defendants submitted false Medicare claims; those allegations remain contested and return to the lower court.

Read the source: Eleventh Circuit: Published opinion in United States ex rel. Zafirov v. Florida Medical Associates ↗

What qui tam litigation actually does

The False Claims Act allows the federal government to seek damages and civil penalties when a person knowingly submits false claims for public money. Its qui tam provisions also allow a private relator with information about suspected fraud to file in the government's name.

The Justice Department receives the complaint under seal and may investigate before deciding whether to intervene. Even when the government declines, the relator may sometimes continue, subject to statutory controls. A successful relator generally receives 15 percent to 30 percent of the recovery, depending on the government's role and other factors.

That financial incentive is controversial, but it is not a secret bounty created by a court. Congress wrote it into 31 U.S.C. Section 3730 as part of an enforcement system whose roots extend to the Civil War era.

Read the source: Reuters: U.S. appeals court upholds False Claims Act whistleblower provision ↗

The panel rejected the Appointments Clause theory

The district court had reasoned that a relator exercises significant federal enforcement power and therefore must be appointed like an executive-branch officer. The appellate panel rejected that premise because a relator does not occupy an ongoing federal office and cannot launch a portfolio of cases for the government.

The opinion also emphasized the government's continuing statutory authority, including its ability to intervene, seek dismissal and limit a relator's participation. Those controls helped explain why the lawsuit does not convert a private plaintiff into an unappointed federal prosecutor.

The ruling aligns the Eleventh Circuit with earlier appellate decisions that sustained qui tam litigation. Recent separate opinions by several Supreme Court justices had renewed debate, however, so the constitutional question may still attract further review.

Read the source: U.S. Code: False Claims Act civil actions and relator provisions ↗

The Medicare allegations remain unproven

Zafirov alleges that the defendants improperly coded medical conditions in Medicare Advantage records, causing the government to pay more than it should have. The defendants deny wrongdoing and had won dismissal on the constitutional issue before the factual claims were fully adjudicated.

Reinstating a complaint is not the same as finding fraud. The parties may contest evidence, legal elements, damages and defenses in later proceedings, and the Justice Department's support for the statute does not establish liability in this particular case.

Precise reporting therefore separates two outcomes: the whistleblower mechanism survived this appeal, while the underlying payment allegations remain allegations.

Read the source: Justice Department: False Claims Act overview ↗

Why the broader context matters

The political stakes surrounding the Eleventh Circuit's September 1 ruling that False Claims Act qui tam relators are not federal officers who must be appointed under Article II extend beyond the immediate dispute because government decisions can change who exercises authority, who receives reliable information and who ultimately answers to the public. Scrutiny of the underlying documents is therefore more useful than treating partisan reactions as proof that either side has already prevailed.

Federal agencies, elected officials and judges have different responsibilities, and those responsibilities should not be collapsed into a single narrative about the administration. Readers should distinguish an agency action from a judicial order, a funding commitment from a completed payment, and a reported allegation from a finding established through an official proceeding.

For taxpayers, federal contractors, health-care providers and whistleblowers who use or defend against False Claims Act litigation, the practical consequence depends on what officials actually implement rather than what advocates, critics or social-media accounts predict. That distinction matters particularly when a dispute remains active and the available record could change through an appeal, a formal announcement, congressional oversight or subsequent reporting.

Read the source: Wikimedia Commons: Public-domain photograph of the Eleventh Circuit courthouse ↗

Why the ruling matters beyond one lawsuit

False Claims Act cases touch health care, defense contracting, disaster programs and other areas where private entities receive federal money. Invalidating qui tam suits across a large appellate region could have disrupted investigations and recoveries built around insider information.

The decision instead keeps that channel open in Alabama, Florida and Georgia. It also gives other courts a fresh appellate analysis as defendants continue testing the statute against modern separation-of-powers doctrine.

For taxpayers, the central accountability question is not whether every whistleblower is correct. It is whether credible allegations can be examined under rules that protect due process while allowing the government to recover money obtained through proven fraud.

The strongest available account comes from the Eleventh Circuit's published opinion, the False Claims Act itself and Reuters reporting on the ruling, which provides the clearest basis for checking the underlying facts against claims circulating elsewhere. Independent reporting and official guidance serve different purposes: one can document a developing dispute, while the other helps establish the governing requirements, current procedures and questions that still need an answer.

There are important limits to what can be established now. The ruling resolves the Appointments Clause issue for this appeal, but it does not prove the Medicare-fraud allegations, prevent further review or guarantee that the whistleblower will recover money. Treating an unresolved question as settled would give readers a certainty the available evidence does not support. New statements, updated documents or additional reporting could clarify the situation, but none should be presumed before they appear.

The next meaningful development to watch is proceedings in the Middle District of Florida and any request for rehearing or Supreme Court review. Until then, people directly affected should rely on the institution responsible for the decision or service, check the dates attached to public guidance and be cautious about summaries that omit the legal, financial or local context.